$CTV
Innovid Corp. Stock $ctv

$ctv Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000183537822000134 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$33.70M	$34.47M	$64.32M
YoY Change	29.77%	-46.41%
Cost Of Revenue	$8.376M	$8.534M	$12.42M
YoY Change	56.06%	-31.28%
Gross Profit	$25.32M	$25.94M	$51.91M
YoY Change	22.92%	-50.03%
Gross Profit Margin	75.14%	75.24%	80.69%
Selling, General & Admin	$20.56M	$22.77M	$34.12M
YoY Change	4.8%	-33.26%
% of Gross Profit	81.18%	87.8%	65.74%
Research & Development	$6.842M	$7.312M	$16.93M
YoY Change	-10.99%	-56.82%
% of Gross Profit	27.02%	28.19%	32.62%
Depreciation & Amortization	$2.662M	$1.882M	$156.0K
YoY Change	1429.89%	1106.41%	-67.5%
% of Gross Profit	10.51%	7.26%	0.3%
Operating Expenses	$30.06M	$30.08M	$51.05M
YoY Change	10.11%	-41.07%
Operating Profit	-$4.739M	-$6.031M	$853.0K
YoY Change	-29.29%	-807.03%
Interest Expense	$2.693M	-$4.962M	-$3.878M
YoY Change	-630.12%	27.95%
% of Operating Profit			-454.63%
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.046M	-$10.99M	-$3.025M
YoY Change	-71.62%	263.4%
Income Tax	$1.383M	$839.0K	$829.0K
% Of Pretax Income
Net Earnings	-$3.429M	-$11.83M	-$3.854M
YoY Change	-54.99%	207.01%
Net Earnings / Revenue	-10.18%	-34.33%	-5.99%
Basic Earnings Per Share		-$0.09	-$0.45
Diluted Earnings Per Share	-$0.03	-$0.09	-$32.40K
COMMON SHARES
Basic Shares Outstanding	133.7M shares	132.4M shares	18.85M shares
Diluted Shares Outstanding		133.0M shares	18.85M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.54M	$46.51M	$14.47M
YoY Change	-69.66%	221.37%
Cash & Equivalents	$37.54M	$46.51M	$14.47M
Short-Term Investments
Other Short-Term Assets	$616.0K	$3.812M	$1.966M
YoY Change	22.47%	93.9%
Inventory
Prepaid Expenses	$1.721M
Receivables	$43.65M	$40.22M	$34.22M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$93.83M	$90.54M	$50.66M
YoY Change	-51.94%	78.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.32M	$11.72M	$3.298M
YoY Change	195.91%	255.34%
Goodwill	$117.0M	$114.7M
YoY Change	2468.08%
Intangibles	$29.92M	$34.21M
YoY Change
Long-Term Investments	$277.0K	$310.0K	$317.0K
YoY Change	-10.65%	-2.21%
Other Assets	$938.0K	$795.0K	$4.321M
YoY Change	708.62%	-81.6%
Total Long-Term Assets	$165.8M	$165.3M	$12.49M
YoY Change	1512.09%	1223.6%
TOTAL ASSETS
Total Short-Term Assets	$93.83M	$90.54M	$50.66M
Total Long-Term Assets	$165.8M	$165.3M	$12.49M
Total Assets	$259.6M	$255.9M	$63.15M
YoY Change	26.31%	305.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.361M	$2.950M	$2.564M
YoY Change	-33.13%	15.05%
Accrued Expenses	$5.474M	$6.573M	$11.44M
YoY Change	77.61%	-42.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change	-100.0%
Total Short-Term Liabilities	$21.19M	$22.11M	$14.00M
YoY Change	-3.04%	57.9%
LONG-TERM LIABILITIES
Long-Term Debt	$20.00M	$15.00M	$6.000M
YoY Change		150.0%
Other Long-Term Liabilities	$6.554M	$3.918M	$6.544M
YoY Change	89.7%	-40.13%
Total Long-Term Liabilities	$32.49M	$28.79M	$12.54M
YoY Change	44.87%	129.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.19M	$22.11M	$14.00M
Total Long-Term Liabilities	$32.49M	$28.79M	$12.54M
Total Liabilities	$53.68M	$50.90M	$26.55M
YoY Change	21.23%	91.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.9M	-$147.5M
YoY Change	13.9%
Common Stock	$13.00K	$13.00K
YoY Change	8.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$205.9M	$205.0M	-$41.29M
YoY Change
Total Liabilities & Shareholders Equity	$259.6M	$255.9M	$63.15M
YoY Change	26.31%	305.17%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$3.429M	-$11.83M	-$3.854M
YoY Change	-54.99%	207.01%
Depreciation, Depletion And Amortization	$2.662M	$1.882M	$156.0K
YoY Change	1429.89%	1106.41%	-67.5%
Cash From Operating Activities	-$1.473M	$5.813M	-$1.301M
YoY Change	-73.06%	-546.81%	-47.54%
INVESTING ACTIVITIES
Capital Expenditures	$3.192M	-$3.520M	-$1.143M
YoY Change	-286.01%	207.96%	-242.88%
Acquisitions
YoY Change
Other Investing Activities	-$9.447M	$6.000K	-$34.00K
YoY Change	34888.89%	-117.65%	-168.0%
Cash From Investing Activities	-$12.64M	-$3.514M	-$1.177M
YoY Change	625.13%	198.56%	56.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.168M	181.0K	515.0K
YoY Change	-96.54%	-64.85%	-94.61%
NET CHANGE
Cash From Operating Activities	-1.473M	5.813M	-1.301M
Cash From Investing Activities	-12.64M	-3.514M	-1.177M
Cash From Financing Activities	5.168M	181.0K	515.0K
Net Change In Cash	-8.944M	2.480M	-1.963M
YoY Change	-106.29%	-226.34%	-131.01%
FREE CASH FLOW
Cash From Operating Activities	-$1.473M	$5.813M	-$1.301M
Capital Expenditures	$3.192M	-$3.520M	-$1.143M
Free Cash Flow	-$4.665M	$9.333M	-$158.0K
YoY Change	24.37%	-6006.96%	-95.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001835378
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40048
	dei	Entity Registrant Name EntityRegistrantName	Innovid Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3769599
	dei	Entity Address Address Line1 EntityAddressAddressLine1	30 Irving Place,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10003
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	966-7555
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	133650579	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46509000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156696000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	69000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	81000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40223000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35422000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3812000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3131000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	90544000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	195249000	usd
CY2022Q3	iacb	Long Term Other Deposit LongTermOtherDeposit	310000	usd
CY2021Q4	iacb	Long Term Other Deposit LongTermOtherDeposit	310000	usd
CY2022Q3	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	406000	usd
CY2021Q4	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	462000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11719000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4840000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	114678000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	4555000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	34206000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3217000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	795000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	116000	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	165331000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10283000	usd
CY2022Q3	us-gaap	Assets Assets	255875000	usd
CY2021Q4	us-gaap	Assets Assets	205532000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2950000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5026000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10682000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7742000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6573000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3082000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1904000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	22109000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21850000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15000000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2279000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3918000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3455000	usd
CY2022Q3	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	7590000	usd
CY2021Q4	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	18972000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28787000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22427000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	50896000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	44277000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133492514	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	133492514	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119017380	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119017380	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	352423000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293719000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147457000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-132476000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	204979000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161255000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	255875000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	205532000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34469000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23469000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93419000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64324000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	8534000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	4548000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	21811000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	12359000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7312000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5342000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24276000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16698000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13726000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8689000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38397000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23366000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9046000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3982000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30456000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10561000	usd
CY2021Q3	iacb	Finance Expenses Net FinanceExpensesNet	707000	usd
	iacb	Finance Expenses Net FinanceExpensesNet	-10655000	usd
	iacb	Finance Expenses Net FinanceExpensesNet	3878000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1882000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	156000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3481000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	487000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6031000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	752000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25002000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	853000	usd
CY2022Q3	iacb	Finance Expenses Net FinanceExpensesNet	4962000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10993000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14347000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3025000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11832000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	839000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	304000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	634000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	829000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11832000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-259000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14981000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3854000	usd
CY2022Q3	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	usd
CY2021Q3	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	8189000	usd
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	usd
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	52993000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11832000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8448000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8448000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7449000	usd
CY2021Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	21076000	usd
CY2021Q2	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	21076000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1440000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	61000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1659000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14981000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14981000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-56847000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-56847000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.32
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.32
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132959511	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18849710	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129768724	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13157022	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18849710	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129768724	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132959511	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13157022	shares
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	86997000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-49730000	usd
CY2021Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	23728000	usd
CY2021Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	23728000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	280000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	306000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1936000	usd
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	110725000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-74808000	usd
CY2021Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	8189000	usd
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	131801000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-96042000	usd
CY2021Q3	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	8189000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	591000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	513000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-259000	usd
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	73690340	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	139990000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-103386000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161255000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	47152000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1496000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	462000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	202916000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4628000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	174000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	4300000	usd
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	212018000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4612000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	181000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11832000	usd
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	204979000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14981000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16092000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	710000	usd
	iacb	Decrease In Operating Lease Right Of Use Assets DecreaseInOperatingLeaseRightOfUseAssets	1332000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3854000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3481000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	487000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9956000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2311000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11382000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3191000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1294000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-581000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-514000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1587000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1032000	usd
	iacb	Decrease In Operating Lease Right Of Use Assets DecreaseInOperatingLeaseRightOfUseAssets	0	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2227000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	355000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46915000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14917000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1782000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2872000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	852000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10089000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3046000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	99568000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	6975000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1049000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	282000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	378000	usd
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	usd
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	459000	usd
	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	38000	usd
	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	-58000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-106787000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1944000	usd
	iacb	Repayment Of Acquisition Liability RepaymentOfAcquisitionLiability	0	usd
	iacb	Repayment Of Acquisition Liability RepaymentOfAcquisitionLiability	126000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3033000	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	3185000	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	817000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	882000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6632000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2277000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-110243000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1175000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157158000	usd
CY2021Q4	iacb	Temporary Equity Secondary Sale Amount TemporaryEquitySecondarySaleAmount	68855000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	727000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	216000	usd
	us-gaap	Interest Paid Net InterestPaidNet	371000	usd
	us-gaap	Interest Paid Net InterestPaidNet	189000	usd
	iacb	Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued	47152000	usd
	iacb	Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued	0	usd
	iacb	Noncash Preferred Stock Accretion Of Redemption Value NoncashPreferredStockAccretionOfRedemptionValue	0	usd
	iacb	Noncash Preferred Stock Accretion Of Redemption Value NoncashPreferredStockAccretionOfRedemptionValue	52993000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	2406000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46509000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14472000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	406000	usd
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	445000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46915000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14917000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	12359000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	156000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	21811000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Prior period reclassification:<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022, we presented depreciation and amortization expenses as a separate line item on our condensed consolidated statements of operations and all prior periods have been adjusted. Depreciation and amortization expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our condensed consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification is to better reflect the financial performance of transactions with customers as our business has evolved and include our most recent acquisition. The change provides more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation and amortization, and better align with how our peers and competitors present their financial statements. </span></div>In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The condensed consolidated balance sheets, condensed statements of changes in temporary equity and stockholders’ equity (deficit), and the condensed consolidated statements of cash flows are not affected by this reclassification.
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	8534000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	4548000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7312000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5342000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13726000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8689000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9046000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3982000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1882000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24276000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16698000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38397000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23366000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30456000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10561000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3481000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	487000	usd
	us-gaap	Use Of Estimates UseOfEstimates	Use of estimates:The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The COVID-19 pandemic created, and continues to create significant uncertainty in macroeconomic conditions, including supply chain disruptions and labor shortages. Further, other global events such as the war in the Ukraine and the current macro-economic inflationary environment could have an impact on our customers. Based on public reporting and our observations, some advertisers in certain industries decreased and may continue to decrease their short-term advertising spending considering some or all of these factors. This in turn could negatively impact our revenues from such advertisers.The Company has considered the impact of COVID-19 and other global events on its estimates and assumptions and determined that there were no material adverse impacts on the unaudited interim condensed consolidated financial statements for the three and nine-month period ended September 30, 2022 (unaudited). As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods.
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q2	iacb	Business Acquisition Accrued Transaction Costs BusinessAcquisitionAccruedTransactionCosts	3185000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations of credit risks:<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s cash and cash equivalents are invested in deposits with major banks in US and Israel. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net is mainly derived from sales to customers located in the APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div>The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
	iacb	Revenue From Contract With Customer Payment Term RevenueFromContractWithCustomerPaymentTerm	P60D
CY2022Q3	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.772
CY2021Q3	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.988
	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.809
	iacb	Revenue Recognition Advertisement Serving And Creative Services Percentage RevenueRecognitionAdvertisementServingAndCreativeServicesPercentage	0.986
CY2022Q3	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.225
CY2021Q3	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.011
	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.188
	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.009
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1.337
CY2021	iacb	Accrued Direct Transaction Cost AccruedDirectTransactionCost	3185000	usd
CY2021	iacb	Accrued Transaction Cost Not Yet Paid AccruedTransactionCostNotYetPaid	3185000	usd
CY2021	iacb	Temporary Equity Secondary Sale Amount TemporaryEquitySecondarySaleAmount	68855000	usd
CY2021	iacb	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	31160000	usd
CY2021	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	6199000	usd
CY2021	iacb	Net Proceeds From The Transaction Before Secondary Sale Amount NetProceedsFromTheTransactionBeforeSecondarySaleAmount	149252000	usd
CY2021	iacb	Warrant Assumed As Part Of Transaction WarrantAssumedAsPartOfTransaction	22791000	usd
CY2021	iacb	Payments Of Reverse Recapitalization Transaction Costs Warrants PaymentsOfReverseRecapitalizationTransactionCostsWarrants	2750000	usd
CY2021	iacb	Reverse Recapitalization Net Of Transaction Costs Before Secondary Sale Amount ReverseRecapitalizationNetOfTransactionCostsBeforeSecondarySaleAmount	126026000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	10000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	20000	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1	shares
CY2021Q4	iacb	Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination	P30D
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3217000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4183000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1904000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2279000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4183000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	466000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1413000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	126000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	334000	usd
	iacb	Fractional Shares Issued Upon Exercise FractionalSharesIssuedUponExercise	0	shares
	iacb	Threshold Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination	P30D
CY2022Q3	us-gaap	Lease Cost LeaseCost	602000	usd
	us-gaap	Lease Cost LeaseCost	1767000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.031
	us-gaap	Operating Lease Payments OperatingLeasePayments	1688000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	iacb	Right Of Use Assets Obtained In Exchange For Operating Lease Liabilities Upon Lease Modification RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiabilitiesUponLeaseModification	610000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	471000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2160000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1035000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	695000	usd
CY2022Q3	iacb	Lessee Operating Lease Liability Undiscounted Lease Payments LesseeOperatingLeaseLiabilityUndiscountedLeasePayments	4361000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	178000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4183000	usd
CY2022Q3	iacb	Bank Guarantees In Connection With Office Lease Agreement BankGuaranteesInConnectionWithOfficeLeaseAgreement	231000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	290000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	780000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	152000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5401000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7D
CY2022Q3	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	839000	usd
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18849710	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129768724	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13157022	shares
CY2021Q3	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	304000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34469000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23469000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93419000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64324000	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	14936000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4840000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11832000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-259000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14981000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3854000	usd
CY2022Q3	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	0	usd
CY2021Q3	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	8189000	usd
	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	0	usd
	iacb	Preferred Stocks Accretion To Redemption Value Adjustment PreferredStocksAccretionToRedemptionValueAdjustment	52993000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11832000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11832000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8448000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8448000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14981000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14981000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-56847000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-56847000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132959511	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18849710	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129768724	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13157022	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132959511	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.32
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.32

Files In Submission

Name	View Source	Status
0001835378-22-000134-index-headers.html	Edgar Link	pending
0001835378-22-000134-index.html	Edgar Link	pending
0001835378-22-000134.txt	Edgar Link	pending
0001835378-22-000134-xbrl.zip	Edgar Link	pending
exhibit311q3.htm	Edgar Link	pending
exhibit312q3.htm	Edgar Link	pending
exhibit321q3.htm	Edgar Link	pending
exhibit322q3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iacb-20220930.htm	Edgar Link	pending
iacb-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
iacb-20220930_cal.xml	Edgar Link	unprocessable
iacb-20220930_def.xml	Edgar Link	unprocessable
iacb-20220930_lab.xml	Edgar Link	unprocessable
iacb-20220930_pre.xml	Edgar Link	unprocessable
iacb-20220930_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTV
Innovid Corp. Stock $ctv

2022 Q4 Form 10-Q Financial Statement

#000183537822000134 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV Innovid Corp. Stock $ctv

2022 Q4 Form 10-Q Financial Statement

#000183537822000134 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV
Innovid Corp. Stock $ctv